Prognostic importance of the fusion partners and measurable residual disease in patients with acute myeloid leukemia who harbor 11q23/KMT2A alterations

Detalles Bibliográficos
Autor principal: Mrózek, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644025/
https://www.ncbi.nlm.nih.gov/pubmed/37969120
http://dx.doi.org/10.21037/tp-23-360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644025/
https://www.ncbi.nlm.nih.gov/pubmed/37969120
http://dx.doi.org/10.21037/tp-23-360

Ejemplares similares